In a world obsessed with consumer genomics and AI hype, IntegraGen operates in the shadows of the French healthcare system, doing the unglamorous work that actually saves lives. With just 61 employees and a modest $9.5M in revenue, they've carved out a defensible niche in molecular diagnostics that giants like Illumina often overlook.

"They're not trying to be the next 23andMe—they're building the infrastructure that makes precision medicine actually work in hospitals."

The tech stack tells a story of pragmatic efficiency. They're running on jQuery, Bootstrap, and Tailwind CSS—no fancy React frameworks or bleeding-edge stacks. This isn't a startup burning VC cash on flashy frontend engineering. It's a mature operation focused on functionality over flash. The presence of core-js and Vite shows they're modernizing incrementally, not rebuilding from scratch every two years.

• 61-person team generating $9.5M = $155K revenue per employee (highly efficient for diagnostics)
• 52% traffic from undefined sources suggests direct relationships and word-of-mouth referrals
• French market dominance (only two countries shown) indicates strong local regulatory moat
• LinkedIn and Twitter presence shows B2B marketing focus, not consumer brand building